Curcumin-Synthetic Analogs Library Screening by Docking and Quantitative Structure-Activity Relationship Studies for AXL Tyrosine Kinase Inhibition in Cancers
- PMID: 31009237
- PMCID: PMC6786334
- DOI: 10.1089/cmb.2019.0052
Curcumin-Synthetic Analogs Library Screening by Docking and Quantitative Structure-Activity Relationship Studies for AXL Tyrosine Kinase Inhibition in Cancers
Abstract
AXL is an important drug target for cancers. Two-dimensional quantitative structure-activity relationship (2D-QSAR) tests were performed to elucidate a relationship between molecular structures and the activity of a series of 400 curcumin derivatives subjected to AXL kinase by ATP competition in the catalytic site. The partial least square regression method implanted in molecular operating environment software was applied to develop QSAR models, which were further validated for statistical significance by internal and external validation. The best model has proven to be statistically robust with a good predictive correlation ofR2 = 0.996 and a significant cross-validation correlation coefficient ofq2 = 0.707. Docking analysis reveled that three curcumin derivatives have the best affinity for AXL and formed a hydrogen bond with the important amino acid residues in the binding pocket. As treated in this article, the docking studies and 2D-QSAR approach will pave the way for the development of new drugs while highlighting curcumin and its derivatives.
Keywords: 2D-QSAR; AXL kinase; internal and external validation; partial least square regression.
Conflict of interest statement
The authors declare there are no competing financial interests.
Figures
![<b>FIG. 1.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6786334/bin/fig-1.gif)
![<b>FIG. 2.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6786334/bin/fig-2.gif)
![<b>FIG. 3.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6786334/bin/fig-3.gif)
![<b>FIG. 4.</b>](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6786334/bin/fig-4.gif)
Similar articles
-
Recent discovery and development of AXL inhibitors as antitumor agents.Eur J Med Chem. 2024 Jun 5;272:116475. doi: 10.1016/j.ejmech.2024.116475. Epub 2024 May 3. Eur J Med Chem. 2024. PMID: 38714043 Review.
-
Development linear and non-linear QSAR models for predicting AXL kinase inhibitory activity of N-[4-(quinolin-4-yloxy)phenyl]benzenesulfonamides.J Recept Signal Transduct Res. 2019 Jun;39(3):264-275. doi: 10.1080/10799893.2019.1660898. Epub 2019 Sep 5. J Recept Signal Transduct Res. 2019. PMID: 31538847
-
Discovering novel 7-azaindole-based series as potent AXL kinase inhibitors.Bioorg Med Chem Lett. 2017 Feb 15;27(4):862-866. doi: 10.1016/j.bmcl.2017.01.015. Epub 2017 Jan 9. Bioorg Med Chem Lett. 2017. PMID: 28094183
-
Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells.Curr Med Chem. 2016;23(15):1496-512. doi: 10.2174/0929867323666160405112954. Curr Med Chem. 2016. PMID: 27048336 Review.
-
3D-QSAR modeling and molecular docking study on Mer kinase inhibitors of pyridine-substituted pyrimidines.Mol Divers. 2015 Feb;19(1):135-47. doi: 10.1007/s11030-014-9556-0. Epub 2014 Oct 30. Mol Divers. 2015. PMID: 25355276
Cited by
-
Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management.Int J Mol Sci. 2024 Mar 2;25(5):2911. doi: 10.3390/ijms25052911. Int J Mol Sci. 2024. PMID: 38474160 Free PMC article. Review.
-
Targeting the GRP78-Dependant SARS-CoV-2 Cell Entry by Peptides and Small Molecules.Bioinform Biol Insights. 2020 Oct 21;14:1177932220965505. doi: 10.1177/1177932220965505. eCollection 2020. Bioinform Biol Insights. 2020. PMID: 33149560 Free PMC article.
References
-
- Anand P., Kunnumakkara A.B., Newman R.A., et al. . 2007. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 4, 807–818 - PubMed
-
- Aoki H., Takada Y., Kondo S., et al. . 2007. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: Role of Akt and extracellular signal-regulated kinase signaling pathways. Mol. Pharmacol. 72, 29–39 - PubMed
-
- Athanasiadis E., Cournia Z., and Spyrou G. 2012. ChemBioServer: A web-based pipeline for filtering, clustering and visualization of chemical compounds used in drug discovery. Bioinforma. Oxf. Engl. 28, 3002–3003 - PubMed
-
- Barclay L.R., Vinqvist M.R., Mukai K., et al. . 2000. On the antioxidant mechanism of curcumin: Classical methods are needed to determine antioxidant mechanism and activity. Org. Lett. 2, 2841–2843 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous